Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>MRI‐based radiomics has been used to diagnose breast lesions; however, little research combining quantitative pharmacokinetic parameters of dynamic contrast‐enhanced MRI (DCE‐MRI) and diffusion kurtosis imaging (DKI) exists.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To develop and validate a multimodal MRI‐based radiomics model for the differential diagnosis of benign and malignant breast lesions and analyze the discriminative abilities of different MR sequences.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 207 female patients with 207 histopathology‐confirmed breast lesions (95 benign and 112 malignant) were included in the study. Then 159 patients were assigned to the training group, and 48 patients comprised the validation group.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>T<sub>2</sub>‐weighted (T<sub>2</sub>W), T<sub>1</sub>‐weighted (T<sub>1</sub>W), diffusion‐weighted MR imaging (b‐values = 0, 500, 800, and 2000 seconds/mm<sup>2</sup>) and quantitative DCE‐MRI were performed on a 3.0T MR scanner. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Radiomics features were extracted from T<sub>2</sub>WI, T<sub>1</sub>WI, DKI, apparent diffusion coefficient (ADC) maps, and DCE pharmacokinetic parameter maps in the training set. Models based on each sequence or combinations of sequences were built using a support vector machine (SVM) classifier and used to differentiate benign and malignant breast lesions in the validation set. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>Optimal feature selection was performed by Spearman's rank correlation coefficients and the least absolute shrinkage and selection operator algorithm (LASSO). Receiver operating characteristic (ROC) curves were used to assess the diagnostic performance of the radiomics models in the validation set.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The area under the ROC curve (AUC) of the optimal radiomics model, including T<sub>2</sub>WI, DKI, and quantitative DCE‐MRI parameter maps was 0.921, with an accuracy of 0.833. The AUCs of the models based on T<sub>1</sub>WI, T<sub>2</sub>WI, ADC map, DKI, and DCE pharmacokinetic parameter maps were 0.730, 0.791, 0.770, 0.788, and 0.836, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>The model based on radiomics features from T<sub>2</sub>WI, DKI, and quantitative DCE pharmacokinetic parameter maps has a high discriminatory ability for benign and malignant breast lesions. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>3</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>2</p></section>

Radiomic Analysis of Pharmacokinetic Heterogeneity Within Tumor Based on the Unsupervised Decomposition of Dynamic Contrast-Enhanced MRI for Predicting Histological Characteristics of Breast Cancer

Radiomics Based On Images Of Pk-Dce Mri To Diagnose Breast Lesions And Predict Molecular Phenotype Of Breast Cancer: Comparison To Quantitative Values Of Pk-Dce Mri

DCE-MRI Based Analysis of Intratumor Heterogeneity by Decomposing Method for Prediction of HER2 Status in Breast Cancer.

A quantitative heterogeneity analysis approach to molecular subtype recognition of breast cancer in dynamic contrast-enhanced magnetic imaging images from radiomics data

Tumour Heterogeneity Revealed by Unsupervised Decomposition of Dynamic Contrast-Enhanced Magnetic Resonance Imaging is Associated with Underlying Gene Expression Patterns and Poor Survival in Breast Cancer Patients

Unsupervised Analysis Based on DCE-MRI Radiomics Features Revealed Three Novel Breast Cancer Subtypes with Distinct Clinical Outcomes and Biological Characteristics

DCE-MRI Texture Analysis with Tumor Subregion Partitioning for Predicting Ki-67 Status of Estrogen Receptor-Positive Breast Cancers.

Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer

Radiogenomic analysis of breast cancer: Dynamic contrast enhanced - Magnetic resonance imaging based features are associated with molecular subtypes

Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy.

Intratumor Heterogeneity of DCE-MRI Reveals Ki-67 Proliferation Status in Breast Cancer

Differentiation Between Luminal A and B Molecular Subtypes of Breast Cancer Using Pharmacokinetic Quantitative Parameters with Histogram and Texture Features on Preoperative Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Radiomic Features of Pk-DCE MRI Parameters Based on the Extensive Tofts Model in Application of Breast Cancer

Radiomic Analysis Reveals DCE-MRI Features for Prediction of Molecular Subtypes of Breast Cancer.

Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions

Heterogeneity Of Tumor And Its Surrounding Stroma On Dce-Mri And Diffusion Weighted Imaging In Predicting Histological Grade And Lymph Node Status Of Breast Cancer

Diffusion-weighted Imaging Features of Breast Tumours and the Surrounding Stroma Reflect Intrinsic Heterogeneous Characteristics of Molecular Subtypes in Breast Cancer

Analysis of DCE-MRI features in tumor and the surrounding stroma for prediction of Ki-67 proliferation status in breast cancer

Comparison of Dynamic Contrast‐Enhanced MRI and Non‐Mono‐Exponential Model‐Based Diffusion‐Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics

Deconvolution-Based Pharmacokinetic Analysis to Improve the Prediction of Pathological Information of Breast Cancer

Radiomic Analysis of Imaging Heterogeneity in Tumours and the Surrounding Parenchyma Based on Unsupervised Decomposition of DCE-MRI for Predicting Molecular Subtypes of Breast Cancer.